Evicenter
P&T meetings

Ivonescimab

EGFR-mutated non-small-cell lung cancer

Launch
Not announced
Last updated
79 sources

Product information and disease descriptionProduct descriptionProduct information

Contraindications/Warnings/Precautions/Adverse effects

3 evidence topics · 2 sources

Warnings and precautions
Summary

The Chinese prescribing information warns that immune-related adverse reactions may be severe, life-threatening, or fatal. The trial safety table below reports treatment-related adverse events; it is not U.S. prescribing information.

Chinese prescribing information: severity of immune-related adverse reactions